ELEPSIA XR 1500 MG
NDC 80705-101, levetiracetam, tablet, extended release, from TRIPOINT THERAPEUTICS, LLC.
- Product NDC
- 80705-101
- Status
- Listed
- Labeler
- TRIPOINT THERAPEUTICS, LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA204417
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/80705-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVETIRACETAM1500 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 80705-101-02 | 80705010102 | 1 BLISTER PACK in 1 CARTON (80705-101-02) / 2 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
| 80705-101-30 | 80705010130 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (80705-101-30) |
| 80705-101-99 | 80705010199 | 1 BLISTER PACK in 1 CARTON (80705-101-99) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/cac83d47-88a2-4447-a0c0-90b44ffda0ac
Use it
Look up 80705-101 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/80705-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 80705-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.